Chemical Component Summary

NameMETA VANADATE
Identifiers[bis(oxidanylidene)vanadio-[[[[bis(oxidanylidene)vanadio-[tris(oxidanylidene)vanadio]-$l^{3}-oxidanyl]-bis(oxidanylidene)vanadio]oxy-bis(oxidanylidene)vanadio]oxy-oxidanylidene-vanadio]-$l^{3}-oxidanyl]-tris(oxidanylidene)vanadium
FormulaO19 V7
Molecular Weight660.579
TypeNON-POLYMER
Isomeric SMILESO=[V](=O)[O@@]([V](=O)(=O)=O)[V](=O)(=O)O[V](=O)(=O)O[V](=O)O([V](=O)=O)[V](=O)(=O)=O
InChIInChI=1S/19O.7V
InChIKeyCTUXFMMCMPZRLK-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count26
Chiral Atom Count0
Bond Count25
Aromatic Bond Count0

Drug Info: DrugBank

DrugBank IDDB02681 
Name2,8-bis[oxido(oxo)vanadio]-1,1,1,3,5,5,7,7,9,9,9-undecaoxopentavanadoxane-2,8-diium
Groups experimental
Synonyms2,8-bis[oxido(oxo)vanadio]-1,1,1,3,5,5,7,7,9,9,9-undecaoxopentavanadoxane-2,8-diium

Drug Targets

NameTarget SequencePharmacological ActionActions
Uridine phosphorylaseMSKSDVFHLGLTKNDLQGATLAIVPGDPDRVEKIAALMDKPVKLASHREF...unknown
Cyclin-dependent kinases regulatory subunit 1MSHKQIYYSDKYDDEEFEYRHVMLPKDIAKLVPKTHLMSESEWRNLGVQQ...unknown
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682